Galmed Pharmaceuticals Ltd.
GLMDDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Aramchol | Phase 2 | Fatty Liver | - | - |
Frequently asked questions
What is in Galmed Pharmaceuticals Ltd.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Galmed Pharmaceuticals Ltd.'s (GLMD) pipeline across Phase 2. Its lead program is Aramchol (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Galmed Pharmaceuticals Ltd.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Galmed Pharmaceuticals Ltd. (GLMD) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GLMD biotech catalysts?→
Add GLMD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Galmed Pharmaceuticals Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.